Search - tctmd.com

Displaying 21 - 40 of 50

Sort: Relevancy | Date

News Opinion Off Script

Off Script: Implicit Bias Can Be a Matter of Life and Death—Let’s Do Something About It

Quinn Capers IV, MD

September 23, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Daily News

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

Michael O'Riordan

August 22, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

Presentation TVT 2019

Machine Learning-Based Prediction of Pacemaker Implantation After Transcatheter Aortic Valve Replacement

Presenter: Anvi Raina

June 14, 2019

Presentation TVT 2019

Predictors of Late (≥ 30 Days) Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

Presenter: Alexis Okoh

June 14, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

Presentation EuroPCR 2019

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Presenter: IJ. Amat-Santos

May 21, 2019

Presentation EuroPCR 2019

Ten year follow-up of patients treated with transcatheter aortic valve implantation

Presenter: Janarthanan Sathananthan

May 21, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

Presentation ARCH 2019

Transcatheter Valve in Valve implantation for Degenerated Surgical Bioprothesis Replacement

Presenter: Cho Mi Young

April 10, 2019

Advertisement

Off Script: Implicit Bias Can Be a Matter of Life and Death—Let’s Do Something About It

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Aborted TAVR Procedures Are Waning in the US

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Machine Learning-Based Prediction of Pacemaker Implantation After Transcatheter Aortic Valve Replacement

Predictors of Late (≥ 30 Days) Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Ten year follow-up of patients treated with transcatheter aortic valve implantation

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Transcatheter Valve in Valve implantation for Degenerated Surgical Bioprothesis Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content